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SResults: Access site cross over was needed in 1 patient (0.002%), and con-
version from sheathless guiding catheter to conventional guiding catheter in 1 patient
(0.002%). Acute procedural success rate was 95. 9%. The median duration of
the procedures was 50min (IQR 41-65). The median time of ﬂuoroscopy was
16.5min(IQR 12.7-23.6). The median contrast media use was 136ml (IQR 110-160).
Guiding catheter-induced coronary artery dissection occurred in 1 patient.
Conclusions: Routine use of the Sheathless guide catheter for TRA in PPCI
for STEMI is feasible with a low crossover rate and a high rate of procedural
success.
TCT-272
Comparative Effectiveness of the Different Arterial Approaches "Transbrachial,
Transradial and Transfemoral" in Percutaneous Coronary Interventions:
Real-world Experiences
Mahmoud M. Sabbah1, Kazushige Kadota2, Yasushi Fuku3, Tsuyoshi Goto3,
Seiji Habara3, Hiroyuki Tanaka3, Kazuaki Mitsudo4
1Faculty of Medicine, Suez Canal University-Ismailia-Egypt, Ismailia-Egypt,
2Kurashiki Central Hospital -Okayama -Japan, Kurashiki, Japan, 3Kurashiki Central
Hospital, Kurashiki, Japan, 4Kurashiki Central Hospital, Okayama, Japan
Background: Up to our knowledge, there's no data investigating the three different
approaches (Transbrachial (TBA), Transradial (TRA) and Transfemoral (TFA) for
PCI .Coping with our daily needs for diversity of tools and approaches we explore our
extensive experiences with the different PCI accesses.
Methods: This retrospective observational,single center trial investigated 4955 CAD
patients underwent coronary revascularization through one of the studied approaches
between April 2006 to June 2012. After application of inclusion and exclusion
criteria.A total of 1102(22.2%),2797(56.4%)and,1054(21.2%)Patients were distrib-
uted through(TBA),TRA)and(TFA)accesses respectively.All patients were retrospec-
tively evaluated regards the predeﬁned primary safety endpoint(In hospital Cardiac
death,MI,stroke,major access site hematoma and/or bleeding)and efﬁcacy endpoints
(Access and procedure success/time,contrast volume,cross over rate and access site
complications.
Results: Over the 7 year study period,our results showed that both TBA and TRA
associated with higher procedural success compared with TFA(P¼0.0001)with no
signiﬁcant difference in access success and time.Both TBA and TRA groups have
shorter ﬂuoroscopy time(P¼0.0001).Regards the safety endpoints, our results
showed that TFA patients have higher rate of MACE and In–Hospital cardiac death
compared with TRA patients(p¼0.008 and 0.01 for MACE and cardiac death
respectively).Such difference is not encountered between TBA and either TRA or
TFA groups,however there was no signiﬁcant difference in MI,stroke,emergency
CABG.TFA group has signiﬁcantly higher incidence of major access site hematoma
(p¼0.0001).Both TBA and TFA groups have higher proportions of access site
pseudoaneurysm(P¼0.001).Primary Safety and efﬁcacy Endpoints between TBA,TRA and,TFA.
TBA (1102) TRA(2797) TFA(1054) P .value
MACE(%) 21(1.9)a,b 33(1.2)a 27(2.6)b 0.008*
Cardiac Death (%) 1(0.1)a,b 2(0.1)a 6(0.6)b 0.001*
Acute MI 20(1.8) 32(1.1) 22(2.1) 0.06
Stroke(%) 2 (0.2) 3 (0.1) 5(0.5) 0.07
Major access site Hematoma (%) 3(0.3)a 4(0.1)a 13(1.2)b 0.0001*
Aneurysm/Pseudo aneurysm (%) 8(0.7)a 1(0.01)b 5(0.5)a 0.001*
Procedure Success(%) 1080(98)a 2752(98.4)a 1008(95.6)b 0.0001*
Procedure time(min) 132.39 9.5 131.53  7.3 131.4  7.8 0.09
Fluoroscopy time (min) 21.1  14.5a 21.8 15.7a 34.7 26.9b 0.000*
Contrast Volume(mL) 111.9 60.1a 124 66.3 171 87.5 0.000x
Data are presented as mean+SD, or the number of patients/arteries (percentage);
TBA¼transbrachial approach; TRA¼transradial aaproach;TFA¼transfemoral approach; *The
same superscript letter denotes column proportions which do not differ signiﬁcantly from
each other at the .05 level,Different superscript letters means signiﬁcant difference between
its column proportions.Conclusions: Based on the previous data, transbrachial approach for PCI could be
a good alternative for the standard of care approaches with considerable safety and
efﬁcacy.JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrTCT-273
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Background: Use of bleeding avoidance strategies (BAS) such as transradial
access, bivalirudin, and femoral closure devices have been shown to lower bleeding
events after PCI but used most often in those at lowest risk of bleeding. Patient
characteristics that deter use of BAS in higher risk patients for bleeding are not clearly
established.
Methods: Patients undergoing PCI at four University of Pittsburgh Medical Center
afﬁliated hospitals were enrolled in a hospital-based registry and followed prospec-
tively beginning in October 2011. Bleeding events and bleeding risk score (BRS) were
deﬁned by NCDR criteria and deﬁnitions. Low risk of bleeding deﬁned as score<13
and high risk of bleeding as score13.
Results: Among 2178 consecutive PCI patients (66.7% for acute coronary syndrome),
978 patients had a calculated BRS of <13 and 1200 patients 13. BAS use more
likely in the low risk group (91.1 vs 83.0%, p¼0.0001). Speciﬁc strategy used in the
low and high-risk groups were femoral access closure only in 23.5 vs 28.2% (p¼0.01),
bivalirudin only in 21.6 vs 21.1% (p¼0.78), transradial access only in 4.1 vs 3.8%
(p¼0.68), and a combination of BAS in 41.9 vs 30% (p¼0.0001). Among the high
risk group, logistic regression was used to determine the independent risk factors
associated with use of BAS (Figure 1).Conclusions: Utilization of a BAS has been increasingly advocated for especially in
high-risk patients for bleeding. However, recognizing deterrents to utilization allows
for understanding if use is even feasible and further studies are necessary to study the
safety and efﬁcacy of BAS in higher risk patients.
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Background: Despite advances in interventional cardiology, and that safety and
feasibility of outpatient percutaneous coronary intervention (PCI) has been previously
demonstrated, overnight stay after PCI remains the standard of care in the United
States. The study aims to compare outcomes, patient satisfaction, and cost of same day
(SD) vs. delayed hospital discharge (DD) after PCI-stenting and femoral hemostasis
with a vascular closure device (StarClose or ProGlide).
Methods: Consecutive patients undergoing coronary angiography (n¼2,480) at
University of Southern California Hospitals were screened; 493 patients were con-
sented for inclusion. Four hours following PCI, 100 patients were randomized to SD
(n¼50) or DD (n¼50). Patients were followed for one month and patient satisfaction
surveys completed at 24 hours and one-month post discharge. Cost savings were
calculated based on Medicare payment rates.
Results: SD and DD groups were well distributed with similar baseline demographic
and angiographic characteristics. Mean age was 58.18.8, 86% were male, 16%
smokers, 44% diabetic, 41% had history of MI and 31% CRI. NSTEMI or
unstable angina (UA) was the presentation in 30% of SD vs. 44% of DD
patients (p¼0.2) and all other patients had stable angina (SA) (70% in DD vs. 56% in
SD, p¼0.15). Multivessel stenting was performed in 74% and 60% of SD and
DD groups, respectively (p¼0.14). At 30 days post-discharge, the primary end
point (death, myocardial infarction or repeat revascularization) occurred in one
DD patient (2%) vs. two SD patients (4%), p¼1.0. The secondary end points ofacts/POSTER/Vascular Access and Closure B89







Smajor non-CABG related bleeding occurred in one SD patient (GI bleed) and
recurrent hospitalization in three patients of SD (6%) vs. one DD patient (2%),
p¼0.62. There were no vascular complications. Patient satisfaction scores were
equivalent in both groups at all time points. SD was associated with $1,200 savings
per patient.
Conclusions: Same day discharge after uncomplicated single and multivessel PCI of
patients with SA, UA and low risk NSTEMI facilitated by vascular device closure is
associated with similar clinical outcomes, patient satisfaction and signiﬁcant cost
savings compared to traditional overnight hospital stay.
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Background: Although acute myocardial infarction (MI) and cardiogenic shock are
known to predict post-percutaneous coronary intervention (PCI) bleeding, the asso-
ciation between post-PCI bleeding and the severity of clinical presentation has not
been clearly deﬁned. This study aims to compare the incidence and predictors of
post-PCI bleeding across different clinical presentations.
Methods: The study included 23943 consecutive PCI patients categorized
according to their clinical presentation: stable angina pectoris (SAP, n¼6741),
unstable angina pectoris (UAP, n¼5215), non-ST-segment elevation MI (NSTEMI,
n¼8418), ST-segment elevation MI (STEMI, n¼2721), and cardiogenic shock (CGS,
n¼848).
Results: There was greater use of pre-procedural anticoagulation, intra-aortic
balloon pump and glycoprotein receptor inhibitors with increasing severity of
clinical presentation. The incidence of Thrombolysis In Myocardial Infarction
(TIMI) major and minor bleeding increases with severity of clinical presenta-
tion.(Figure 1) On multivariate logistic regression analysis,(Figure 2)NSTEMI,
STEMI and CGS remain independently predictive of bleeding after adjusting for
baseline and procedural differences, whereas UAP did not. In-hospital mortality
corresponded with severity of clinical presentation, from 0.2% in SAP to 24.4%
in CGS.
Conclusions: In patients undergoing PCI, the worsening severity of clinical
presentation corresponds to an increase in incidence of post-PCI bleeding. The
increased bleeding risk persisted despite adjusting for more aggressive pharmaco-
therapy and use of IABP with increasing severity of clinical presentation.TCT-276
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Background: Increasingly frequent performing invasive cardiac procedures without
removing oral anticoagulation, however the need for withdrawal of oral anticoagulants
before transradial cardiac catheterization in patients chronically anticoagulated
remains controversial. It is usually removed at least 48-72 hours before the procedureB90 JACC Vol 62/18/Suppl B j October 27–Novand in selected patients, heparin is used as bridge therapy. We evaluate the efﬁcacy
and safety of performing transradial catheterization in outpatients without removal of
warfarin.
Methods: 268 patients undergoing transradial cardiac catheterization. 40 patients
chronically anticoagulated with Acenocumarol(Group A) were compared with the rest
(Group B). The hemostasis technique was similar in both groups as a patent hemo-
stasis assessed by plethysmography (elastic compression with a band during 2 hours).
We assessed the development of complications after the removal of bandage while
patients still were in laboratory and in ﬁrst 24 hours. Radial patency was assessed by
plethysmography and hematomas were classiﬁed according EASY classiﬁcation.
Bleeding and other complications were also recorded.
Results: Patients in Group A were older (728 vs 6511 years old; p¼0,01) without
other difference in baseline characteristics. Atrial ﬁbrillation (60%) was the main
cause for warfarin and the mean INR at the time of procedure was 2,40,5. During the
procedure there wasn’t any remarkable complication and there wasn’t difference in
time for procedure between groups. When the bandage were removed, it was 1,8% of
bleeding in Group B who required new compression (0% in Group A (p>0.05)) and
only one radial occlusion (Group B). No difference in hematomas  5 cm (7.5% vs
6.6%, p>0.05). In ﬁrst 24 hours, no early or late hematomas call for additional
attendance and there was 1.8% late mild bleeding in Group B vs 0% in Group A. No
cases with hematomas >10 cm or extended to the arm, no compartment syndrome and
no other complications as ﬁstulas, pseudoaneurysms, dissections or perforations.
Conclusions: Performing transradial diagnostic cardiac catheterization without
withdrawal of oral chronic anticoagulation is safe, with low rates of thrombotic and
hemorragic complications.
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Background: Increasingly the trans-radial route (TR) is preferred over the trans-
femoral route (TF) for PCI. However even in high volume default TR centres a small
cohort of patients are required to undergo TF PCI. Our study examined the clinical,
procedural characteristics and outcomes of patients undergoing PCI via the TF in
a single high volume UK centre.
Methods: This was a prospective study examining the PCI procedure and outcomes of
all patients undergoing PCI between Jan 2009 and Dec 2012. Patient demographics,
procedure details, and outcomes were all collected from internal and national
databases.
Results: 5379 patients were treated with 10.4% (n¼561) of patients undergoing PCI via
the TF and 89.6% via the TR. The TF group were more often female (35.8 vs. 24.6%
when compared to TR cohort, p<0.0001), older (64.9 vs. 63.0yrs, p<0.0002), and
lighter (80.7 vs. 83.7kgs, p<0.0001). There was a greater proportion of patients with
a history of previous revascularization by PCI (27.5% vs. 18.1%, p<0.0001) or CABG
(14.6 vs. 4.8%, p<0.0001) in the TF group. Cardiogenic shock and use of IABPwas also
greater in the TF group (7 vs. 1% and 6.5 vs. 0.5% respectively, p<0.0001). Complex
procedures including use of rotational atherectomy (4.1 vs. 0.7%), saphenous vein graft
PCI (9.1 vs. 3%) and chronic occlusion PCI (21.1 vs. 6.8%) were also performed more
frequently in the TF group (p<0.0001 for all). In- hospital mortality (2.0 vs. 0.46%,
p<0.0001), vascular complications (3.2 vs. 0.6%), p<0.0001) and bleeding (1.0 vs.
0.02%) were all more common in the TF group. PCI success was less common (88.2 vs.
94.6%) in the TFgroup despite similar number of lesions attempted (1.54 vs. 1.57, p¼ns)
and vessels treated (1.27 vs. 1.27, p¼ns).
Conclusions: In a high volume default TR PCI centre the small cohort of patients
that continue to have PCI via the TF route are more likely to undergo complex
coronary intervention and have higher subsequent vascular complications and
mortality. Best practice for such patients in future will require optimisation of
pharmacotherapy strategies, procedural techniques and utilisation of emerging inter-
ventional equipment.
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Background: Transradial cardiac catheterization reduces bleeding compared with
femoral access, but the initial arterial cannulation can be difﬁcult due to weak pulses,
hypotension, calciﬁcation, obesity or peripheral vascular disease. Multiple attempts atember 1, 2013 j TCT Abstracts/POSTER/Vascular Access and Closure
